Eman Youssef Moursy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eman Youssef Moursy has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Fathy Elsewy
Diabetes & Metabolism Unit, Internal Medicine Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt
1 shared publication - Magdy Helmy Megallaa
Unit of Diabetes, Lipidology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Alexandria University, Alexandria 21526, Egypt
1 shared publication - Mohamed El-Shafei
Radiodiagnosis Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt
1 shared publication - Mohammed Ayman
Cardiology and Angiology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt
1 shared publication - Reham Fadl Mouftah
Department of Clinical Pathology, Faculty of Medicine, Alexandria University, Alexandria, Egypt
1 shared publication - Saeed Yafei
Adult Endocrinology and Diabetes Department, Jazan Endocrinology & Diabetes Center, Jazan Health Cluster, Ministry of Health, Jazan 82723, Saudi Arabia
1 shared publication
Latest Publications
- 1 January 2019
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 13 (1) , 882-888
Fibroblast growth factor 21 association with subclinical atherosclerosis and arterial stiffness in type 2 diabetes
- 1 January 2019
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 13 (1) , 882-888
Fibroblast growth factor 21 association with subclinical atherosclerosis and arterial stiffness in type 2 diabetes
- Open Access
- 23 October 2015
- Published by Science Publishing Group in American Journal of Internal Medicine
- Vol. 3 (6) , 250-255
Relationship Between Neutrophil-Lymphocyte Ratio and Microvascular Complications in Egyptian Patients with Type 2 Diabetes
Several epidemiological studies have shown that chronic inflammation plays a central role in the pathogenesis of diabetes and its various complications. Neutrophil-lymphocyte ratio (NLR) is a novel potential marker in determining inflammation. The aim of this study was to evaluate the relationship between diabetic microvascular complications, namely diabetic retinopathy, nephropathy, neuropathy, and neutrophil-lymphocyte ratio in type 2 diabetic patients. The study took place in the Unit of Diabetes & Metabolism at the Faculty of Medicine, Alexandria University, Alexandria, Egypt, and included a total of 280 subjects, 200 male patients with type 2 diabetes, 108 of them having one or more microvascular complication, and a control group including 80 healthy age and sex-matched subjects. Results of our study showed that neutrophil-lymphocyte ratio (NLR) values were significantly higher in diabetic patients with retinopathy (p<0.001), neuropathy (p=0.025) and nephropathy (p<0.001) than those of diabetic patients without any microvascular complications and healthy control subjects. NLR levels correlated positively with body mass index (BMI) (r=0.436, p<0.001), glycosylated hemoglobin (HbA1c) (r=0.526, p=0.001) and erythrocyte sedimentation rate (ESR) (r=0.396, p=0.017). Based on the results of this study, we can conclude that neutrophil-lymphocyte ratio (NLR), which is an efficient, simple and stable marker of inflammation, can serve as an important predictor for the presence of microvascular complications in Egyptian patients with type 2 diabetes.
- 23 October 2015
- Published by Science Publishing Group in American Journal of Internal Medicine
- Vol. 3 (6) , 250-255
Open AccessRelationship Between Neutrophil-Lymphocyte Ratio and Microvascular Complications in Egyptian Patients with Type 2 Diabetes
Several epidemiological studies have shown that chronic inflammation plays a central role in the pathogenesis of diabetes and its various complications. Neutrophil-lymphocyte ratio (NLR) is a novel potential marker in determining inflammation. The aim of this study was to evaluate the relationship between diabetic microvascular complications, namely diabetic retinopathy, nephropathy, neuropathy, and neutrophil-lymphocyte ratio in type 2 diabetic patients. The study took place in the Unit of Diabetes & Metabolism at the Faculty of Medicine, Alexandria University, Alexandria, Egypt, and included a total of 280 subjects, 200 male patients with type 2 diabetes, 108 of them having one or more microvascular complication, and a control group including 80 healthy age and sex-matched subjects. Results of our study showed that neutrophil-lymphocyte ratio (NLR) values were significantly higher in diabetic patients with retinopathy (p<0.001), neuropathy (p=0.025) and nephropathy (p<0.001) than those of diabetic patients without any microvascular complications and healthy control subjects. NLR levels correlated positively with body mass index (BMI) (r=0.436, p<0.001), glycosylated hemoglobin (HbA1c) (r=0.526, p=0.001) and erythrocyte sedimentation rate (ESR) (r=0.396, p=0.017). Based on the results of this study, we can conclude that neutrophil-lymphocyte ratio (NLR), which is an efficient, simple and stable marker of inflammation, can serve as an important predictor for the presence of microvascular complications in Egyptian patients with type 2 diabetes.